Cevac IBD 2512 L lyophilisate for oral suspension for chickens
Cevac IBD 2512 L lyophilisate for oral suspension for chickens
Authorised
- Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
Product identification
Medicine name:
Cevac IBD 2512 L lyophilisate for oral suspension for chickens
Active substance:
- Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
Target species:
-
Chicken (broiler)
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live3.20/log 10 50% embryo infective dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Lyophilised vaccine: 1,000, 2,500 and 5,000 doses in type I glass vials of 3 ml and 10 ml volume, sealed with rubber stopper and aluminium cap. 20 vials in a box.
- Lyophilised vaccine: 1,000, 2,500 and 5,000 doses in type I glass vials of 3 ml and 10 ml volume, sealed with rubber stopper and aluminium cap. 20 vials in a box.
- Lyophilised vaccine: 1,000, 2,500 and 5,000 doses in type I glass vials of 3 ml and 10 ml volume, sealed with rubber stopper and aluminium cap. 20 vials in a box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva-Phylaxia Zrt.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
Hungary
Procedure number:
- HU/V/0115/001
Concerned member states:
-
Estonia
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Portugal
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 27/08/2025
Lithuanian (PDF)
Published on: 13/01/2026